Product range
My Mercateo
Sign in / Register
Basket
 
 

Rohde & Schwarz FPH-B3 SPA Frequency Upgrade 2GHz to 3GHz, For Use With Spectrum Rider FPH Handheld Spectrum Analyser / 1259493


Quantity:  piece  
Product information
Product Image
Product Image
Item number:
     2794E-1259493
Manufacturer:
     Rohde + Schwarz
Manufacturer no.:
     FPH-B3
EAN/GTIN:
     4250138104989
Search terms:
Measuring equipment software
Measuring device software
Measuring devices software
Software for measuring equipment
FPH-B3 (2 to 3 GHz) is required in order to upgrade to FPH-B4 3 to 4 GHz. FPH-B3 and FPH-B4 SPA Frequency Upgrades for Spectrum Rider. The R ;S®SpectrumRider FPH is the first handheld analyzer with software-upgradeable frequency ranges. The base unit handles frequencies between 5 kHz and 2 GHz. The end frequency of 2 GHz is required for most common lab applications such as EMI pre-compliance or troubleshooting during RF development. Users who need an instrument that supports frequencies above 2 GHz can easily upgrade their instrument to 3 GHz or 4 GHz via software keycode. ; 125-9493 125-9493 - Frequency upgrade 2GHz to 3GHz ; 125-9494 125-9494 - Frequency upgrade 3GHz to 4GHz
More information:
Accessory Type:
SPA Frequency Upgrade 2GHz to 3GHz
For Use With:
Spectrum Rider FPH Handheld Spectrum Analyser
Other search terms: Software for measuring device, Software for measuring devices, Spectrum analyser, Spectrum analyzer, Spectrum analysers, Spectrum analyzers, spectrum analyser, 1259493, Test & Measurement, Signal Generators & Analysers, Spectrum Analyser Accessories, Rohde & Schwarz, FPHB3
An overview of the conditions1
Delivery period
Stock level
Price
£ 754.499*
Select conditions yourself
Share itemAdd item to shopping list
Accessories
We have the following accessories in our assortment:
Type
Picture
Item
Manufacturer/Manufacturer no.
Price
Accessories
Rohde + Schwarz
FPH
£ 4,301.511*
* Prices with asterisk are net prices excl. statutory VAT.
Our offer is only aimed at companies, public institutions and freelancers.